1-12 of 12
Noushin Farnoud, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clonal Hematopoiesis and Its Implications for Flow Cytometric Assessment of Measurable Residual Disease in Patients with NPM1- mutated Acute Myeloid Leukemia

Sanam Loghavi, MD, Courtney D. DiNardo, MD MSCE, Koichi Takahashi, MD PhD, Rashmi Kanagal-Shamanna, MD, Tomoyuki Tanaka, MDPhD, Ken Furudate, DDM, PhD, Nicholas J. Short, MD, Tapan M. Kadia, MD, Marina Konopleva, MD PhD, Noushin Farnoud, PhD, Sherry A. Pierce, BSN, BA, Joseph D. Khoury, MD, Jeffrey L. Jorgensen, MD PhD, Keyur P. Patel, MBBS, PhD, L. Jeffrey Medeiros, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MBBS, Sa A Wang, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-139871
Published: 2020
Journal Articles

Molecular Predictors and Effectiveness of Measurable Residual Disease (MRD) Eradication with Chemotherapy and Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Maximilian Stahl, MD, Andriy Derkach, PhD, Christopher Famulare, MS, Christina Cho, MD, Sean Devlin, PhD, Noushin Farnoud, PhD, Kamal Menghrajani, MD, Minal A Patel, MPH, Sheng F Cai, MDPhD, Mark B. Geyer, MD, Andrew Dunbar, MD, Zachary D. Epstein-Peterson, MD, Erin McGovern, BA, Jessica Schulman, BSc, Jacob L Glass, MDPhD, Justin Taylor, MD, Aaron D Viny, MDMS, Eytan M. Stein, MD, Bartlomiej Getta, FRCPA, FRACP, MBBS, Maria E. Arcila, MD, Ross L. Levine, MD, Juliet Barker, MBBS, Brian C. Shaffer, MD, Esperanza B. Papadopoulos, MD, Boglarka Gyurkocza, MD, Miguel-Angel Perales, MD, Omar Abdel-Wahab, MD, Elli Papaemmanuil, PhD, Sergio A. Giralt, MD, Yanming Zhang, MD, Mikhail Roshal, MD PhD, Martin S. Tallman, MD, Aaron D Goldberg, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–20.
https://doi.org/10.1182/blood-2020-137552
Published: 2020
Journal Articles

Expansion of Prior Existing TP53 Mutated Clones in Polycythemia Vera Patients Treated with Idasanutlin

Bridget Marcellino, MD PhD, Bruno Cassinat, PharmD, PhD, Noushin Farnoud, PhD, Min Lu, PhD, Emmanuelle Verger, PhD, Erin McGovern, BA, Minal A Patel, MPH, Heidi E. Kosiorek, MS, Meenakshi Mehrotra, PhD, Jane Houldsworth, PhD, Amylou C. Dueck, PhD, Michael Rossi, PhD, Jean-Jacques Kiladjian, MD PhD, Raajit K. Rampal, MD PhD, John Mascarenhas, MD, Ronald Hoffman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 838.
https://doi.org/10.1182/blood-2019-128342
Published: 2019
Journal Articles

Landscape of TP53 Mutations in MPN

Noushin Farnoud, PhD, Christopher Famulare, MS, Elli Papaemmanuil, PhD, Erin McGovern, BA, Juan Medina, MS, Juan E. Arango Ossa, BS, Raajit K. Rampal, MD PhD, Bing Li, MD, Ross L. Levine, MD, John Mascarenhas, MD, Rona Singer Weinberg, PhD, Minal A Patel, MPH, Ronald Hoffman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1681.
https://doi.org/10.1182/blood-2019-132014
Published: 2019
Journal Articles

Significance of Abnormalities of PPM1D in Myeloproliferative Neoplasms

Bridget Marcellino, MD PhD, Joseph Tripodi, Michal Bar-Natan, MD, Harry Fruchtman, Noushin Farnoud, PhD, Min Lu, PhD, Heidi E. Kosiorek, MS, Amylou C. Dueck, PhD, Raajit K. Rampal, MD PhD, John Mascarenhas, MD, Vesna Najfeld, PhD, Ronald Hoffman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4207.
https://doi.org/10.1182/blood-2019-129565
Published: 2019
Journal Articles

The Genetic Architecture of Myeloproliferative Neoplasms-Blast Phase (MPN-BP) Stem Cells

Xiaoli Wang, MD PhD, Raajit K. Rampal, MD PhD, Cing Siang Hu, Noushin Farnoud, PhD, Christopher Famulare, MS, Minal A Patel, MPH, Erin McGovern, BA, Ronald Hoffman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1677.
https://doi.org/10.1182/blood-2019-128836
Published: 2019
Journal Articles

Molecular Predictors and Current Management of Minimal Residual Disease (MRD) Following Induction Chemotherapy for Acute Myeloid Leukemia (AML)

Aaron D Goldberg, MDPhD, Christopher Famulare, MS, Sean M Devlin, PhD, Noushin Farnoud, PhD, Kamal Menghrajani, MD, Minal Patel, BA, Sheng Cai, MD PhD, Andrew Dunbar, MD, Zachary D. Epstein-Peterson, MD, Erin McGovern, BA, Jessica Schulman, Jacob L Glass, MDPhD, Justin Taylor, MD, Aaron D Viny, MDMS, Bartlomiej Getta, FRCPA, FRACP, MBBS, Maria E Arcila, MD, Ross L. Levine, MD, Brian C. Shaffer, MD, Boglarka Gyurkocza, MD, Esperanza B. Papadopoulos, MD, Miguel-Angel Perales, MD, Elli Papaemmanuil, PhD, Sergio Giralt, MD, Yanming Zhang, MD, Mikhail Roshal, MD PhD, Martin S. Tallman, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 292.
https://doi.org/10.1182/blood-2018-99-112938
Published: 2018
Journal Articles

Early Detection and Molecular Characterization of Therapy-Related Leukemia in Children Reveals Patterns of Disease Transformation and Guides Future Surveillance Protocols

Barbara Spitzer, MD, Gunes Gundem, PhD, Noushin Farnoud, PhD, Nathan Millard, MD, Erin McGovern, BA, Minal Patel, BA, Max Levine, MS, Juan Medina, MS, Yangyu Zhou, BS, Juan E. Arango Ossa, BS, Michael Francis Walsh, MD, Ross L. Levine, MD, Irene Y. Cheung, ScD, Scott A. Armstrong, MD PhD, Nai-Kong V. Cheung, MD PhD, Elli Papaemmanuil, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 291.
https://doi.org/10.1182/blood-2018-99-120005
Published: 2018
Journal Articles

Alisertib (MLN8237), an Oral Selective Inhibitor of Aurora Kinase a, Has Clinical Activity and Restores GATA1 Expression in Patients with Myelofibrosis

Naseema Gangat, MBBS, Brady Lee Stein, MD, Christian Marinaccio, Ronan Swords, MD PhD, Justin M. Watts, MD, Sandeep Gurbuxani, Olga Frankfurt, MD, Jessica K. Altman, MD, Jeremy Q. Wen, MD PhD, Noushin Farnoud, PhD, Christopher Famulare, MS, Akshar Patel, BA, Roberto Tapia, BS, Amy Handlogten, Yvonne Trang Dinh, BS, Kristen Englund, Shradha Patel, Juan Carlos Nobrega, Dalissa Tejera, MSN, Amber Thomassen, Harald Stein, MD PhD Dr. h.c., Juehua Gao, MD PhD, Peng Ji, MDPhD, Raajit K. Rampal, MD PhD, Francis J. Giles, MD FRCPI, FRCPath, Ayalew Tefferi, MD, John D. Crispino, PhD MBA
Journal: Blood
Blood (2018) 132 (Supplement 1): 688.
https://doi.org/10.1182/blood-2018-99-110381
Published: 2018
Journal Articles

TP53 Mutations Predict Poorer Responses to CPX-351 in Acute Myeloid Leukemia

Aaron D Goldberg, MD PhD, Chetasi Talati, MD, Pinkal Desai, MD MPH, Christopher Famulare, MS, Sean M Devlin, PhD, Noushin Farnoud, PhD, David A Sallman, MD, Jeffrey E. Lancet, MD, Gail J. Roboz, MD, Kendra L. Sweet, MD, Martin S. Tallman, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1433.
https://doi.org/10.1182/blood-2018-99-117772
Published: 2018
Journal Articles

A Knowledge-Based Approach for Clinical Annotation of Oncogenic Variants to Support Patient-Tailored Diagnosis in Myeloid Disease

Elsa Bernard, PhD, Kenichi Yoshida, MD PhD, Gunes Gundem, PhD, Jacob Grinfeld, MBChB, BSc, MRCP, FRCPath, Jyoti Nangalia, MBBChir, MA, MRCP, FRCPath, PhD, Daniel Leongamornlert, PhD, Noushin Farnoud, PhD, Juan Medina, Matahi Moarii, PhD, Charlie Massie, PhD, Yasunobu Nagata, MD PhD, Yusuke Okuno, MD PhD, Torsten Haferlach, MD, Seishi Ogawa, MD PhD, Amanda Gilkes, Oliver G. Ottmann, MD, Robert K. Hills, DPhil, Nigel H. Russell, Brian J.P Huntly, Anthony R Green, PhD FRCP, FRCPath, FMedSci, Alan K. Burnett, MD, Peter Campbell, PhD, Elli Papaemmanuil, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1414.
https://doi.org/10.1182/blood.V130.Suppl_1.1414.1414
Published: 2017
Journal Articles

Molecular Profiling in Extramedullary Acute Myeloid Leukemia Reveals Distinct Subgroups Defined By Mutations in KIT and RUNX1

Aaron D Goldberg, MD, Noushin Farnoud, PhD, Cody Goldberger, Minal Patel, BA, Christopher Famulare, MS, Juan Medina, Raajit K. Rampal, MD PhD, Ross L. Levine, MD, Ellin Berman, MD, Yanming Zhang, MD, Filiz Sen, MD, Elli Papaemmanuil, PhD, Martin S. Tallman, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2663.
https://doi.org/10.1182/blood.V130.Suppl_1.2663.2663
Published: 2017